Supplements for Female Fertility: CoQ10, Inositol, and Folate

Female fertility is a complex interplay of egg quality, ovarian reserve, hormonal signaling, uterine receptivity, and systemic health. Declining egg quality is the primary age-related barrier to conception after 35, and it is driven by mitochondrial dysfunction and oxidative damage to the oocyte (egg cell). Supplements that support mitochondrial function, reduce oxidative stress, optimize hormone balance, and improve endometrial receptivity have meaningful clinical evidence for improving natural conception rates and IVF outcomes.

CoQ10: Mitochondrial Power for Eggs

Coenzyme Q10 is the most evidence-backed fertility supplement for women, particularly for age-related egg quality decline. Egg maturation (meiosis) is among the most energetically demanding processes in the body - requiring enormous mitochondrial ATP output. As women age, mitochondrial function in oocytes declines, increasing the risk of chromosomal errors (aneuploidy) that cause miscarriage and failed implantation.

Supplementation with 400-600 mg of CoQ10 (as ubiquinol for women over 35) daily has been shown to improve oocyte quality, fertilization rates, and embryo quality in women undergoing IVF. A Toronto randomized trial found that CoQ10 600 mg daily for 60 days before IVF increased the number of mature eggs retrieved and fertilized, and reduced aneuploidy rates. For women trying to conceive naturally, 200-600 mg daily starting 3-6 months before intended conception is the standard recommendation. Ubiquinol (reduced form) is superior to ubiquinone for women over 35.

Myo-Inositol: PCOS and Ovulation Support

Myo-inositol is a naturally occurring compound that acts as a second messenger in insulin and FSH signaling. In women with PCOS (polycystic ovary syndrome) - the most common cause of anovulatory infertility - insulin resistance at the ovarian level impairs follicular development and egg maturation. Myo-inositol restores insulin signaling in ovarian granulosa cells, improving egg quality and restoring ovulation.

Multiple RCTs have demonstrated that myo-inositol (4 grams daily, with or without 400 mcg folate in a 40:1 myo-inositol:D-chiro-inositol ratio) significantly improves ovulation rate, egg quality, and clinical pregnancy rates in women with PCOS. The combination product Ovasitol (myo-inositol + D-chiro-inositol in 40:1 ratio) is widely used by reproductive endocrinologists. For PCOS, inositol is the single most evidence-backed supplement available.

Methylfolate: DNA Integrity and Neural Tube Prevention

Folate is essential for DNA methylation and synthesis in rapidly dividing cells - including the fertilized egg and early embryo. Inadequate folate is the leading preventable cause of neural tube defects. For women planning pregnancy, 400-800 mcg of methylfolate (5-MTHF, the bioactive form) is universally recommended starting at least one month before conception.

Women with MTHFR gene variants (C677T or A1298C) have impaired conversion of folic acid to active folate and should use methylfolate exclusively rather than folic acid. Testing MTHFR status before conception is increasingly common in reproductive medicine. Higher doses (1-5 mg methylfolate) may be recommended by providers in specific clinical situations such as prior neural tube defect pregnancy or known homocysteine elevation.

DHEA: Ovarian Reserve Support

DHEA (dehydroepiandrosterone) is an adrenal androgen that supports ovarian function by acting as a substrate for estrogen synthesis in follicles and by enhancing the response of follicular cells to FSH. Declining DHEA with age is associated with declining ovarian reserve (low AMH, high FSH).

Several RCTs and retrospective studies in women with diminished ovarian reserve (DOR) undergoing IVF found that 25-75 mg of micronized DHEA daily for 3-6 months before egg retrieval significantly improved number of eggs retrieved, fertilization rates, and clinical pregnancy rates. DHEA has the strongest evidence in women with low AMH and high FSH. It is not recommended for women with PCOS (already have elevated androgens) or hormone-sensitive conditions. Test DHEA-S levels before supplementing.

Vitamin D and Omega-3: Systemic Foundation

Vitamin D receptors are expressed in ovarian follicles and the uterine endometrium; deficiency is associated with lower IVF success rates and higher miscarriage rates. Target serum levels of 50-80 ng/mL for fertility optimization. Omega-3 DHA supports oocyte membrane fluidity, embryo quality, and reduces uterine inflammation. 2-3 grams EPA+DHA daily is the fertility-optimized dose.

FAQ

How long before trying to conceive should I start fertility supplements? At minimum, begin methylfolate 1-3 months before intended conception. For CoQ10 and DHEA, which influence egg quality over the 90-day follicular maturation cycle, start 3-6 months before attempting conception or beginning IVF stimulation.

Can these supplements help with unexplained infertility? Yes - oxidative stress and mitochondrial dysfunction affect egg quality in women of all diagnoses, not just those with a specific identified cause. CoQ10 and a comprehensive antioxidant approach is appropriate for all women experiencing fertility challenges, regardless of diagnosis.

Is DHEA safe to take without testing? DHEA supplementation without baseline DHEA-S testing is not ideal, as women with PCOS or already-normal DHEA levels do not benefit and may be harmed by additional androgens. Test first, supplement only if levels are low-normal or below normal for age.

Related Articles

• Myo-Inositol and D-Chiro-Inositol for PCOS Fertility
• AHCC: Immune Mushroom Extract for HPV and Cervical Health
• Best Supplements for Women Over 40
• Calcium for PMS: Why It's the Most Evidence-Based Supplement
• Choline in Pregnancy: The Overlooked Essential Nutrient

Track your supplements in Optimize.